Is CBD safe? FDA Update Offers Little New Information
The U.S. Food and Drug Administration gave a congressionally mandated update Friday on its progress in determining the safety of products with cannabidiol (CBD) -- a report that reiterated the agency's previously stated concerns without offering a lot of new information. The 2020 spending bills signed by President Trump in December required a report on "the agency's progress toward obtaining and analyzing data to help determine a policy of enforcement discretion and the process in which CBD meeting the definition of hemp will be evaluated for use in products."
The FDA repeated its earlier statements about potential ways that CBD products could be harmful, including the possibilities for liver injury, drug interactions, male reproductive toxicity, and side effects. It also noted the lack of data about the effects of long-term use or whether CBD might pose greater risks to more vulnerable populations such as children, pregnant and lactating women, the elderly, and fetuses.
Image source: Getty Images.
Source Fool.com
